Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports

BACKGROUND: Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved better clinical improvement after bedaquiline is stopped at 24 wk. However, there is no recommend...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jing-Tao, Xie, Li, Ma, Li-Ping, Shu, Wei, Zhang, Li-Jie, Ning, Yu-Jia, Xie, Shi-Heng, Liu, Yu-Hong, Gao, Meng-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026830/
https://www.ncbi.nlm.nih.gov/pubmed/33869610
http://dx.doi.org/10.12998/wjcc.v9.i10.2326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026830/
https://www.ncbi.nlm.nih.gov/pubmed/33869610
http://dx.doi.org/10.12998/wjcc.v9.i10.2326

Ejemplares similares